UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. PATH's revenue growth re-accelerated to 15.9% in Q3 FY26, with raised full-year ...

Software developer UiPath will cut 10% of its workforce, or about 420 jobs, as part of a broader company restructuring. UiPath shares fell 7% on Tuesday and have plunged more than 50% year-to-date. In ...

UiPath is rated a buy at $12, trading at 15x FY2027 and 13x FY2028 earnings, with strong 80%+ gross margins. Revenue grew 17% to $418M in Q1 FY2027, ARR rose 12% to $1.9B, and non-GAAP operating ...

UiPath's software automates menial digital tasks, freeing people up for more meaningful jobs. This sounds an awful lot like one of the benefits of generative AI, which explains customers' confusion.

The main goal of robotic process automation is to relieve the burden of mind-numbing, monotonous and repetitive processes. From a value perspective, an autonomous robot can help reduce staffing costs ...